|
ZNF273 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.65230093233049E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95830018867582E-10 |
| Normal-vs-Stage2 |
4.998100E-02 |
| Normal-vs-Stage3 |
6.73969768882898E-11 |
| Normal-vs-Stage4 |
1.10110000006713E-07 |
| Stage1-vs-Stage2 |
6.405800E-02 |
| Stage1-vs-Stage3 |
2.250000E-01 |
| Stage1-vs-Stage4 |
2.489800E-01 |
| Stage2-vs-Stage3 |
1.803830E-02 |
| Stage2-vs-Stage4 |
2.257600E-02 |
| Stage3-vs-Stage4 |
8.201200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6825986704514E-11 |
| Normal-vs-AfricanAmerican |
2.0162999999962E-05 |
| Normal-vs-Asian |
4.038600E-04 |
| Caucasian-vs-AfricanAmerican |
9.130000E-01 |
| Caucasian-vs-Asian |
2.409600E-01 |
| AfricanAmerican-vs-Asian |
3.750200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.09349999949582E-07 |
| Normal-vs-Female |
2.53469467637046E-11 |
| Male-vs-Female |
2.108200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.07969999397062E-09 |
| Normal-vs-Age(41-60Yrs) |
5.34310040656294E-10 |
| Normal-vs-Age(61-80Yrs) |
1.58079999978966E-07 |
| Normal-vs-Age(81-100Yrs) |
1.84138000000056E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.991200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.893200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.125000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.498000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.188200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.265000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.57050000068904E-08 |
| Classical-VS-Follicular |
1.724460E-02 |
| Classical-VS-Other |
3.420000E-01 |
| Classical-VS-Normal |
6.69539979014644E-10 |
| Tall-VS-Follicular |
4.94179996923805E-09 |
| Tall-VS-Other |
4.850300E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.058800E-01 |
| Follicular-VS-Normal |
1.383970E-03 |
| Other-VS-Normal |
1.359360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.89530005420846E-09 |
| Normal-vs-N1 |
3.94910000001136E-06 |
| N0-vs-N1 |
5.986800E-01 |
|
|
